Evidence map›Paper›PMID 30030373›Full record

ArticleThe Journal of biological chemistry2018

The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice.

Qingwei Zhu, Amanda Chang, Albert Xu, Kunxin Luo

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Aging · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. [Role of microRNA-17-5p in the pathogenesis of pediatric nephrotic syndrome and related mechanisms].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Qingwei ZhuFrom the Department of Molecular and Cell Biology, University of California, Berkeley, California 94720.
Amanda ChangFrom the Department of Molecular and Cell Biology, University of California, Berkeley, California 94720.
Albert Xuthe Department of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, California 94158-2140.
Kunxin LuoFrom the Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, kluo@berkeley.edu.
University of California, Berkeley · USHoward Hughes Medical Institute · USLawrence Berkeley National Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ski-related oncogene SnoN (SnoN or SKIL) regulates multiple signaling pathways in a tissue- and developmental stage-dependent manner and has broad functions in embryonic angiogenesis, mammary gland alveologenesis, cancer, and aging. Here, we report that SnoN also plays a critical role in white adipose tissue (WAT) development by regulating mesenchymal stem cell (MSC) self-renewal and differentiation. We found that SnoN promotes MSC differentiation in the adipocyte lineage by antagonizing activin A/Smad2, but not TGFβ/Smad3 signaling. Mice lacking SnoN or expressing a mutant SnoN defective in binding to the Smads were protected from high-fat diet-induced obesity and insulin resistance, and MSCs lacking a functional SnoN exhibited defective differentiation. We further demonstrated that activin, via Smad2, appears to be the major regulator of WAT development

Indexed as

Cell DifferentiationObesitySignal TransductionActivinsAdipocytesAdipose Tissue, WhiteAnimalsMesenchymal Stem CellsMiceProto-Oncogene ProteinsSmad2 Proteinactivin AActivinsProto-Oncogene ProteinsSkil protein, mouseSmad2 Proteinactivinadipocyteadipose tissuedifferentiationobesitySKILSKI like proto-oncogeneSmad2SMAD transcription factorSnoNtransforming growth factor β (TGF-β)

Identifiers

PMID30030373
PMCPMC6130966
OpenAlexW2883291686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.